相关实验视频

Updated: Jun 24, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

CEP55:对于肝细胞癌免疫疗法和生存的影响

Yanhong Wang^1,2, Long Zhang^1,2, Jianhui Tian^1,2

¹Clinical Oncology Center, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200071, China.

Combinatorial chemistry & high throughput screening

|June 7, 2024

概括

在肝细胞癌 (HCC) 组织中,CEP55显著升高,与晚期疾病阶段和较差的患者存活率相关. 这一发现突出了CEP55作为HCC的潜在预后标志物,有助于治疗指导.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
生物信息学是一种生物信息学.

背景情况:

肝细胞癌 (HCC) 是一种流行且具有攻击性的癌症,需要改善预后标志物.
CEP55是一种微管结合蛋白,在细胞生长和分裂中起作用.

研究的目的:

调查HCC中CEP55基因变异及其对疾病发展的影响.
评估CEP55作为HCC的潜在预后生物标志物.

主要方法:

对CEP55表达,变异和甲基化的GEO和TCGA数据集进行全面的生物信息学分析.
探索CEP55与临床病理特征,生存和免疫透的关联.
在HCC细胞系中对CEP55表达的RT-qPCR验证.

主要成果:

在HCC和其他16种癌症中,CEP55的升高调节,与瘤阶段,等级和AFP水平相关.
高CEP55表达预测了更糟糕的患者结果,并准确地区分了HCC和正常组织.
CEP55的变化与细胞循环途径和免疫细胞透有关.

结论:

在HCC中,CEP55受到上调,并作为一个重要的预后指标.
CEP55与疾病阶段和存活率的关联强调了其作为治疗点的潜力.

关键词:

CEP55 CEP55是什么意思肝细胞癌预后肝细胞癌预后单细胞测序是一种单细胞测序.生物信息学是一种生物信息学.生物标志物生物标志物免疫疗法免疫疗法

更多相关视频

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...